Pharmacy

In a setback to states working to rein in prescription drug costs, the U.S. Supreme Court rejected Maryland's bid to revive a law aimed at preventing price gouging by drugmakers, Reuters reports.

After facing pressure from hedge fund Appaloosa LP to separate the roles of chairman and CEO, Allergan announced its intent to do so.

Ohio Attorney General Dave Yost wants UnitedHealth Group's pharmacy benefit arm OptumRx to repay $16 million to the Bureau of Workers' Compensation, according to The Columbus Dispatch.

CVS Health and Walgreens, the two largest retail pharmacy chains in the U.S., have both opened redesigned health-focused stores.

Drugstores at CVS and Walgreens are being renovated to look more like physician offices, according to CNBC.

The following drug, medical device recalls have occurred in the last month:

AstraZeneca saw sales rise 4 percent, to $21 billion, in fiscal year 2018, marking its strongest growth since 2009, according to The Wall Street Journal.

Using the Netflix-style payment model for purchasing hepatitis C drugs is expected to lower patient costs in Australia by 85 percent, according to a new study published in the New England Journal of Medicine, cited by STAT.

The three big insulin makers, Novo Nordisk, Eli Lilly and Sanofi, must face a lawsuit that claims they gouged diabetes patients with the price of their lifesaving medications, according to Bloomberg.

When drug prices rise and reimbursement rates remain stagnant, hospitals that purchase large quantities of pharmaceuticals find themselves in a financially vulnerable position.